Product name:Vorinostat
CAS: 149647-78-9
Molecular Formula: 14H20N2O3
Molecular Weight: 264.32
Product description:For new drugs for the treatment of skin cancer. The drug is the Merck, the development of the world's first new cancer drugs inhibiting histone acetyl off enzyme, used in the treatment of skin t-cell lymphoma (CTCL), approved by FDA for other drug treatment or after treatment still cannot be cured, or worse, or illness repeated cases of metastatic skin T cell tumor. A large number of experimental and clinical study results show that vorinostat for a wide variety of tumor has good curative effect, and other tumor drug combination has obvious synergy, the treatment of other tumor study also in further, these results suggest that vorinostat has broad market prospects.